Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab in low back pain
ISRCTN15955788Phase 4Completed
- Sponsor
- University Hospital of Geneva
- Start
- Jun 2013
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of adalimumab in chronic low back pain (CLBP), sponsored by University Hospital of Geneva. Primary endpoints: Pain intensity and Roland Disability Questionnaire score. Started Jun 2013; status: completed.
02
Drugs
03
Conditions
chronic low back pain (CLBP)
Beyond the preview
Go deeper on ISRCTN15955788.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN15955788.